A Novel MSE Score to Predict rHCC Patients

Completed

• Conditions: HCC
• Interventions: Procedure: hepatectomy

• Registration Number: NCT05450874
• Lead Sponsor: Tongji Hospital

Brief Summary

Develop and validate a novel scoring system based on pathological factors to predict the postoperative survival of patients with rHCC.Patients with rHCC who underwent hepatectomy were recruited from two hospitals.Exploring whether this scoring system is related to prognosis

Detailed Description

Not available

Study Timeline

• Study Start: 2010-02-01
• Primary Completion: 2017-03-01
• Status Verified: 2022-06
• Study Completion: 2022-06-01
• Study First Submitted: 2022-07-05
• Study First Submitted QC: 2022-07-08
• Last Update Submitted: 2022-07-08
• Study First Posted: 2022-07-11
• Last Update Posted: 2022-07-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• a diagnosis of ruptured tumor confirmed by enhanced computed tomography (CT) and/or abdominal magnetic resonance imaging (MRI),
• a diagnosis of HCC made by two experienced pathologists

Exclusion Criteria

• extrahepatic HCC metastasis
• death within 1 month after surgery

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Training cohort	hepatectomy	-
Validation cohort	hepatectomy	-

Primary Outcome Measures

Name	Time	Method
overall survival	2010-2022	Time from the first postoperative day to survival at the last follow-up